CLINICAL TRIALS PROFILE FOR VANOXERINE
✉ Email this page to a colleague
Clinical Trials for Vanoxerine
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00218049 ↗ | Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals | Terminated | University of Texas | Phase 1 | Cocaine dependence is a major public health problem; an effective primary treatment for cocaine dependent individuals has yet to be found. The purpose of this study is to determine the safety and effects of vanoxerine (GBR 12909) in treating cocaine dependent individuals. |
NCT00218049 ↗ | Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals | Terminated | National Institute on Drug Abuse (NIDA) | Phase 1 | Cocaine dependence is a major public health problem; an effective primary treatment for cocaine dependent individuals has yet to be found. The purpose of this study is to determine the safety and effects of vanoxerine (GBR 12909) in treating cocaine dependent individuals. |
NCT01691313 ↗ | Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm | Completed | Laguna Pharmaceuticals, Inc. | Phase 2 | Evaluate the safety and efficacy of a single oral dose of vanoxerine compared to placebo, in a dose modification manner, on the conversion of symptomatic atrial fibrillation (a-fib) or flutter of recent onset to normal sinus rhythm. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Vanoxerine
Condition Name
Clinical Trial Locations for Vanoxerine
Trials by Country
Clinical Trial Progress for Vanoxerine
Clinical Trial Phase
Clinical Trial Sponsors for Vanoxerine
Sponsor Name